BioSpace News Archive

Late-Breaking Clinical Study Results Demonstrate Exceptional Safety and Efficacy Outcomes for Resolute Onyx(TM) DES

TCT18: BIONYX Study Shows Strong Performance with Durable Polymer Resolute Onyx DES in Head-to-Head Comparison with Biodegradable Polymer DES

September 25, 2018
·
4 min read
Business

MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders

MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company’s Annual Report to shareholders.

September 25, 2018
·
3 min read
FDA

Verastem Gets FDA Approval for Leukemia Drug, Will Make It Immediately Available to Patients

Shares of Verastem closed out Monday trading on a positive note and continues to climb in the premarket following the greenlight for leukemia drug Copiktra, an inhibitor of phosphoinositide 3-kinase (PI3K)-delta and PI3K-gamma.

September 25, 2018
·
3 min read
·
Alex Keown
Drug Development

Is NASH Really a $35 Billion Opportunity?

Is NASH Really a $35 Billion Opportunity? And could it be the middle of the pack that wins the prize? For the last few years, investors have been talking up the huge potential of drugs to treat nonalcoholic steatohepatitis, also known as NASH.

September 25, 2018
·
4 min read
·
Karl Thiel
Drug Development

Survey Says: Top 5 Trends in the Life Sciences Industry

Recently, BioSpace posted a question on its website, under the heading, “We Want to Hear from You! Top Life Sciences Trends.” Let’s take a look at the five trends survey participants mentioned.

September 25, 2018
·
5 min read
·
Mark Terry
Why “Kissing Up” to Your Boss Could Backfire at Work

Going out of your way to overly ingratiate yourself with your boss (aka “kissing up”) may not be the most ‘attractive’ quality to display in the workplace, but there’s no denying that being proactive about getting your boss on your side can have some positive results … for the short term, anyway.

September 25, 2018
·
2 min read
·
Editorial Staff
Genetown

Updated: Medtech Infraredx Anticipates Trial Data Will Support ‘Holy Grail’ of Cardiovascular Imaging Tool

A new cardiovascular imaging tool could prevent the possibility of people experiencing a second or third heart attack.

September 25, 2018
·
3 min read
·
Alex Keown
Drug Development

Atox Bio Announces Independent Safety Monitoring Committee Recommendation to Continue Phase 3 Study of Reltecimod in Necrotizing Soft Tissue Infections

Atox Bio today announced the independent Data Monitoring Committee (DMC) completed its pre-planned safety review of the first 200 patients enrolled in the company’s ACCUTE trial

September 25, 2018
·
3 min read
Business

QMA expands global distribution, naming Liisa Juntunen to lead U.K. consultant relationships

QMA continues to expand its outreach to clients around the world, today naming Liisa Juntunen as head of U.K. consultant relations.

September 25, 2018
·
3 min read
Juniper Research: ‘Just Walk Out’ Shopping & Other Smart Checkout Tech to Reach Over $45 Billion Transactions by 2023, As Retailers Strive to Eliminate Lines

Transaction volume to grow at over 150% per annum over the next 5 years, but will remain niche; representing under 1% of all retail transactions

September 25, 2018
·
2 min read